Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bird Flu”

214 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 214 results

Testing effectiveness (Phase 2)Study completedNCT03283319
What this trial is testing

Panblok H7 Vaccine Adjuvanted With AS03 or MF59

Who this might be right for
Influenza, Human
Biomedical Advanced Research and Development Authority 366
Early research (Phase 1)Study completedNCT01995695
What this trial is testing

Safety and Immunogenicity of a Live Attenuated H7N9 Influenza Virus Vaccine in Healthy Adults

Who this might be right for
Influenza A Virus, H7N9 Subtype
National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)Study completedNCT01195038
What this trial is testing

Immunogenicity and Safety Study of a Booster Vaccination With a Recombinant H5N1 Influenza HA Vaccine in Primed Adults

Who this might be right for
Influenza
UMN Pharma Inc. 87
Early research (Phase 1)Study completedNCT01698060
What this trial is testing

Immunogenicity of ND1.1 by Delivery Directly to the Ileum

Who this might be right for
Avian Influenza
Vaxart 12
Testing effectiveness (Phase 2)WithdrawnNCT01037634
What this trial is testing

Safety and Efficacy of Oseltamivir in Children Younger Than One Year of Age

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID)
Post-approval studies (Phase 4)Study completedNCT03701061
What this trial is testing

Durability and Impact of the Seasonal Influenza Vaccine on H5 Induced B Cell Response

Who this might be right for
Influenza A Subtype H5N1 Infection
Emory University 12
Testing effectiveness (Phase 2)Looking for participantsNCT06842173
What this trial is testing

Safety and Immunogenicity of the Monovalent Influenza Vaccine A (H5N8) (Inactivated, Fragmented and Adjuvanted) in Adults and Older Adults

Who this might be right for
Avian Influenza A Virus
Butantan Institute 700
Early research (Phase 1)Study completedNCT01236040
What this trial is testing

Immunogenicity and Safety of Pandemic Influenza Vaccines in Adults Aged 18 - 49 Years Old

Who this might be right for
Influenza
GlaxoSmithKline 521
Testing effectiveness (Phase 2)Study completedNCT04669691
What this trial is testing

A Dose-ranging Pediatric Study of an Adjuvanted Pandemic Influenza Vaccine

Who this might be right for
Influenza, Human
Seqirus 420
Early research (Phase 1)Study completedNCT01184976
What this trial is testing

Study Of VGX-3400, H5N1 Avian Flu Virus Plasmid DNA With Electroporation Device In Healthy Adult Males

Who this might be right for
Healthy
GeneOne Life Science, Inc. 30
Large-scale testing (Phase 3)Looking for participantsNCT07240558
What this trial is testing

Pandemic Influenza Vaccine in Organ Transplantation (PIVOT Trial)

Who this might be right for
Influenza (Pandemic)Avian InfluenzaVaccination
University Health Network, Toronto 120
Testing effectiveness (Phase 2)Study completedNCT01766921
What this trial is testing

Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Elderly Subjects

Who this might be right for
Pandemic H5N1 Influenza
Novartis Vaccines 1,393
Testing effectiveness (Phase 2)Study completedNCT03738241
What this trial is testing

2017 A/H7N9 IIV Revaccination

Who this might be right for
Avian InfluenzaInfluenza Immunisation
National Institute of Allergy and Infectious Diseases (NIAID) 304
Early research (Phase 1)Study completedNCT01928472
What this trial is testing

Dose-finding Study of Four Dosage Levels of an H7N9 Influenza Vaccine in Adults Between Ages of 18 Years and 65 Years

Who this might be right for
H7N9 Influenza
Novartis Vaccines 402
Early research (Phase 1)Study completedNCT06417853
What this trial is testing

Influenza A (H7N9) Vaccine Delivered Intradermally by High-density Microarray Patch (HD-MAP)

Who this might be right for
H7N9 Influenza
Vaxxas Pty Ltd 267
Testing effectiveness (Phase 2)Study completedNCT03755427
What this trial is testing

An Adjuvanted Inactivated H7N9 Influenza Vaccine

Who this might be right for
H7N9 Influenza
Shanghai Institute Of Biological Products 560
Early research (Phase 1)Study completedNCT02957656
What this trial is testing

Safety and Immunogenicity of Priming With Live Attenuated A/H7N9 Influenza Virus Vaccine Followed By Inactivated A/H7N9 Influenza Virus Vaccine With AS03 Adjuvant

Who this might be right for
Influenza A Virus, H7N9 Subtype
National Institute of Allergy and Infectious Diseases (NIAID) 53
Early research (Phase 1)Study completedNCT00755703
What this trial is testing

Safety and Immunogenicity Study of Adenovirus-vectored, Intranasal Pandemic Influenza Vaccine.

Who this might be right for
Influenza A Subtype H5N1 Infection
Altimmune, Inc. 48
Early research (Phase 1)Study completedNCT01658800
What this trial is testing

Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49

Who this might be right for
Influenza
VaxInnate Corporation 275
Testing effectiveness (Phase 2)Study completedNCT00481065
What this trial is testing

Immunogenicity, Safety and Tolerability of Prepandemic Influenza and Seasonal Influenza Vaccine in Adult Subjects

Who this might be right for
PandemicAvian Influenza
Novartis 405
Next Page